Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Interactive Q&A: Joe Cross, President and CEO of Nanophase Technologies

March 4th, 2008

Interactive Q&A: Joe Cross, President and CEO of Nanophase Technologies

Abstract:
This interactive Q&A is with Joe Cross, President and CEO of Nanophase Technologies (NASDAQ: NANX). Nanophase has sponsored this interview, which works like this:

* Joe briefly introduces himself and the issues he's focused on below.
* Readers and contributors can immediately start to post questions and remarks using the comment box below (free SA registration required).
* Seeking Alpha editors will not filter or edit the questions and comments from readers, except to delete profane or hostile language.
* Joe will respond to the questions and remarks beginning Monday, March 3rd. Readers can track his answers and respond to them during that period, with the resulting dialogue remaining on the site.

Readers from external sites may join the Q&A by following this link. seekingalpha.com/article/65806

Source:
seekingalpha.com

Bookmark:

Related News Press

News and information

Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013

Microneedle-Delivered Nanoparticles Boost Antitumor Vaccines May 20th, 2013

Competition in the Quantum World May 20th, 2013

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals

Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013

Protein 'Passport' Helps Nanoparticles Get Past Immune System May 20th, 2013

Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013

Microneedle-Delivered Nanoparticles Boost Antitumor Vaccines May 20th, 2013

Patents/IP/Tech Transfer/Licensing

NanoInk, Inc. Assets To Be Sold May 18th, 2013

HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013

Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013

Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone May 7th, 2013